SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-23-005150
Filing Date
2023-01-25
Accepted
2023-01-25 16:41:28
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea172171-424b5_jasperther.htm 424B5 635240
2 GRAPHIC image_001.jpg GRAPHIC 8757
3 GRAPHIC image_002.jpg GRAPHIC 108804
4 GRAPHIC image_003.jpg GRAPHIC 30456
  Complete submission text file 0001213900-23-005150.txt   840549
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267777 | Film No.: 23552906
SIC: 2836 Biological Products, (No Diagnostic Substances)